Results 181 to 190 of about 4,368 (201)

Finerenone in Heart Failure

JAMA Cardiology
Sama, Samankan, Taher, Entezari-Maleki
openaire   +2 more sources

CV benefits of finerenone in T2DM and CKD

Nature Reviews Cardiology, 2021
openaire   +2 more sources

Determination of Finerenone in Finerenone Tablets by HPLC

Advances in Analytical Chemistry
openaire   +1 more source

A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy

Journal of Diabetes and Its Complications, 2017
Shigehiro Katayama, Peter Kolkhof, Christina Nowack   +2 more
exaly  

Finerenone in Heart Failure—Reply

JAMA Cardiology
Muthiah, Vaduganathan, John J V, McMurray, Scott D, Solomon   +2 more
openaire   +2 more sources

Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone – results from first-in-man and relative bioavailability studies

Fundamental and Clinical Pharmacology, 2016
Silvia Lentini, Roland Heinig, Georg Wensing   +2 more
exaly  

Finerenone/Metformin

Reactions Weekly
openaire   +1 more source

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94–8862) in Individuals With Renal Impairment

Clinical Pharmacology in Drug Development, 2016
Silvia Lentini, Roland Heinig, Atef Halabi   +2 more
exaly  

Finerenone and Kidney Outcomes in Patients With Heart Failure

Journal of the American College of Cardiology
Faiez Zannad, John McMurray
exaly  

Finerenone Withdrawal

JACC
openaire   +1 more source